Department of Cardiovascular Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
J Health Popul Nutr. 2024 Sep 9;43(1):142. doi: 10.1186/s41043-024-00626-z.
Renal Denervation (RDN) is a novel non-pharmacological technique to treat hypertension. This technique lowers blood pressure by blocking the sympathetic nerve fibers around the renal artery, then causing a decrease in system sympathetic nerve excitability. This study aimed to visualize and analyze research hotspots and development trends in the field of RDN for hypertension through bibliometric analysis.
In total, 1479 studies were retrieved on the Web of Science Core Collection (WoSCC) database from 2004 to 2023. Using CiteSpace (6.2.R4) and VOSviewer (1.6.18), visualization maps were generated by relevant literature in the field of RDN for hypertension to demonstrate the research status and frontiers.
The number of publications was found to be generally increasing. Europe and the United States were the first countries to carry out research on different techniques and related RDN clinical trials. The efficacy and safety of RDN have been repeatedly verified and gained increasing attention. The study involves multiple disciplines, including the cardiovascular system, peripheral vascular disease, and physiological pathology, among others. Research hotspots focus on elucidating the mechanism of RDN in the treatment of hypertension and the advantages of RDN in appliance therapy. Additionally, the research frontiers include improvement of RDN instruments and techniques, as well as exploration of the therapeutic effects of RDN in diseases with increased sympathetic nerve activity.
The research hotspots and frontiers reflect the status and development trend of RDN in hypertension. In the future, it is necessary to strengthen international collaboration and cooperation, conduct long-term clinical studies with a large sample size, and continuously improve RDN technology and devices. These measures will provide new options for more patients with hypertension, thereby improving their quality of life.
肾去神经术(RDN)是一种治疗高血压的新型非药物技术。该技术通过阻断肾动脉周围的交感神经纤维来降低血压,从而导致全身交感神经兴奋性降低。本研究旨在通过文献计量分析,可视化和分析高血压 RDN 领域的研究热点和发展趋势。
共从 Web of Science 核心合集数据库(WoSCC)中检索到 2004 年至 2023 年的 1479 项研究。使用 CiteSpace(6.2.R4)和 VOSviewer(1.6.18),生成高血压 RDN 领域相关文献的可视化图谱,以展示研究现状和前沿。
发现出版物数量总体呈增长趋势。欧洲和美国是最早开展不同技术和相关 RDN 临床试验研究的国家。RDN 的疗效和安全性已得到反复验证,并受到越来越多的关注。该研究涉及多个学科,包括心血管系统、外周血管疾病和生理病理学等。研究热点集中在阐明 RDN 在治疗高血压中的作用机制以及 RDN 在器具治疗中的优势。此外,研究前沿包括改进 RDN 仪器和技术,以及探索 RDN 在交感神经活动增加的疾病中的治疗效果。
研究热点和前沿反映了高血压 RDN 的现状和发展趋势。未来有必要加强国际合作与交流,开展大样本量的长期临床研究,不断改进 RDN 技术和器械。这些措施将为更多高血压患者提供新的选择,从而提高他们的生活质量。